Correlation Between HLS Therapeutics and Avicanna

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HLS Therapeutics and Avicanna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLS Therapeutics and Avicanna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HLS Therapeutics and Avicanna, you can compare the effects of market volatilities on HLS Therapeutics and Avicanna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLS Therapeutics with a short position of Avicanna. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLS Therapeutics and Avicanna.

Diversification Opportunities for HLS Therapeutics and Avicanna

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between HLS and Avicanna is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and Avicanna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avicanna and HLS Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLS Therapeutics are associated (or correlated) with Avicanna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avicanna has no effect on the direction of HLS Therapeutics i.e., HLS Therapeutics and Avicanna go up and down completely randomly.

Pair Corralation between HLS Therapeutics and Avicanna

Assuming the 90 days horizon HLS Therapeutics is expected to under-perform the Avicanna. But the pink sheet apears to be less risky and, when comparing its historical volatility, HLS Therapeutics is 1.82 times less risky than Avicanna. The pink sheet trades about -0.02 of its potential returns per unit of risk. The Avicanna is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  32.00  in Avicanna on November 2, 2024 and sell it today you would lose (14.00) from holding Avicanna or give up 43.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.2%
ValuesDaily Returns

HLS Therapeutics  vs.  Avicanna

 Performance 
       Timeline  
HLS Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HLS Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Avicanna 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Avicanna are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Avicanna reported solid returns over the last few months and may actually be approaching a breakup point.

HLS Therapeutics and Avicanna Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HLS Therapeutics and Avicanna

The main advantage of trading using opposite HLS Therapeutics and Avicanna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLS Therapeutics position performs unexpectedly, Avicanna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avicanna will offset losses from the drop in Avicanna's long position.
The idea behind HLS Therapeutics and Avicanna pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas